• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Inflammation speciality position base salary?





































We must’ve had same recruiter bc the one I interviewed with was a complete ditz! No info on the position. All she asked were a bunch of EEO questions. Didn’t say hiring or interviewing timeline, nothing.